The first thing many people are unsure about with medical weight loss is whether to choose Rybelsus (an oral medication) or Mounjaro (a once-weekly injection). It is often said that “injections work better,” but if you choose without knowing why, you may find Rybelsus doesn’t work because you can’t follow the morning dosing rules, or that you can’t keep up with Mounjaro because the injections are a burden. In this article, we lay out the factors for deciding side by side, from differences in how they work to cost, ease of continuing and whether you can switch.
Key points firstIf you are busy, just read this section
- Because it acts on two receptors, Mounjaro may be expected to suppress appetite more strongly
- For getting started, Rybelsus 3 mg is the cheapest
- Choosing the one that fits your lifestyle, not just the stronger one, is what leads to results
What you will learn in this article
- The decisive difference in how the two medications work
- How the effects appear and how long it takes to notice them
- How the costs compare when converted to a monthly amount
- Who each suits, in terms of ease of continuing
- Whether you can switch partway through, and whether they can be used together
- Who cannot use either medication
The biggest difference is “the number of hormones they act on”
Semaglutide, the active ingredient of Rybelsus, acts on the receptor for one hormone, GLP-1. Tirzepatide, the active ingredient of Mounjaro, acts simultaneously on the receptor for GLP-1 and also for GIP, a different hormone.
Both GLP-1 and GIP are hormones called “incretins” that are released from the intestine when you eat. GLP-1 is mainly involved in suppressing appetite and in insulin secretion, while GIP, in addition to regulating blood sugar, is thought to also be involved in the metabolism of fat tissue.
Mounjaro is designed so that acting on both at the same time may be expected to suppress appetite more strongly than a GLP-1-only drug. The basis for the claim that “injections work better” is not just an impression but lies in the difference in the number of sites of action.
Key point
The basis for the claim that “injections work better” is not just an impression but lies in the difference in the number of sites of action.
Comparison by item
| Item | Rybelsus | Mounjaro |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Receptors acted on | GLP-1 | GLP-1+GIP |
| Form | Oral medication (once daily) | Subcutaneous injection (once weekly) |
| Dose | 3mg / 7mg / 14mg | 2.5mg / 5mg / 7.5mg |
| Restrictions on use | On waking, on an empty stomach, with no more than 120 mL of water, and no food or drink for 30 minutes | Inject yourself on a set day of the week |
| Main side effects | Nausea, diarrhea, constipation | Nausea, constipation, vomiting, diarrhea |
| Approval in Japan | Type 2 diabetes | Type 2 diabetes |
| Status when used for weight loss | Off-label use, self-pay treatment | Off-label use, self-pay treatment |
How the effects appear and how long it takes to notice them
Changes in appetite are said to tend to appear sooner with Mounjaro, and changes may occur within a few days of the first injection. Rybelsus has a 3 mg introductory period, so the general guide is that you notice changes about 2 to 4 weeks after the dose is increased to 7 mg.
| Item | Rybelsus | Mounjaro |
|---|---|---|
| Starting dose | 3 mg for about 4 weeks | 2.5 mg for about 4 weeks |
| When you notice changes in appetite | 2 to 4 weeks after increasing to 7 mg | After the first 1 or 2 injections |
| When it shows in your weight | 2 to 3 months after starting | 1 to 2 months after starting |
| Decision to increase the dose | 7 mg → 14 mg if side effects have settled | 5 mg → 7.5 mg if side effects have settled |
However, with both, it takes several weeks to several months for the effects to show in your weight. What they have in common is that neither is a medication for losing a lot of weight in a short time. Don’t judge after a few days; first, check whether how much you eat and how often you snack have changed.
Key point
It takes several weeks to several months for the effects to show in your weight. Don’t judge after a few days; first, check whether how much you eat and how often you snack have changed.
Comparing costs on a monthly basis
Because the forms differ, they cannot be compared as they are. Converting our clinic’s prices (tax incl.) to a per-month figure gives the following. Mounjaro is once weekly, so this assumes about 4 pens per month.
| Medication | Dose | Medication cost per month (approx., tax incl.) |
|---|---|---|
| Rybelsus | 3 mg (starting dose) | ¥8,980 |
| Rybelsus | 7mg | ¥19,980 |
| Rybelsus | 14mg | ¥39,800 |
| Mounjaro | 2.5 mg (starting dose) | ¥4,400 × 4 pens = ¥17,600 |
| Mounjaro | 5mg | ¥6,480 × 4 pens = ¥25,920 |
| Mounjaro | 7.5mg | ¥15,400 × 4 pens = ¥61,600 |
*The Japanese original is authoritative.
For getting started, Rybelsus 3 mg is the cheapest, but once the dose is raised to an effective level, Mounjaro costs more. However, if Rybelsus is raised to 14 mg, it costs ¥39,800, which is more than Mounjaro 5 mg. You cannot simply say that “the oral medication is cheaper.”
The consultation fee is free for both first visits and follow-up visits. If you would like delivery, a shipping fee is charged separately. For the latest prices, please see the price list.
Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
Looking at ease of continuing
Rybelsus may suit you if you
- Really don’t want injections
- Get up at a set time every morning and can go without food or drink for 30 minutes after waking
- Want to try it first while keeping costs down
- Don’t want to keep needles or medication stored at home
Mounjaro may suit you if you
- Are not confident you can follow the morning dosing rules
- Prefer something once a week (don’t want to add another daily task)
- Want to lose a substantial amount of weight
- Have breakfast at different times from day to day
- Often travel for work or stay away from home
It may seem surprising, but many people find it harder to “take a medication properly every day under the same conditions.” If you eat breakfast first or wash the tablet down with coffee, Rybelsus is not absorbed as intended, and you end up “paying for a medication that doesn’t work.” Choosing the one that fits your lifestyle, not just the stronger one, is what ultimately leads to results.
Switching and combined use
You can switch
Switching from Rybelsus to Mounjaro, or the other way round, is possible. However, the doses do not correspond in a simple way, so as a rule, you start again at a low dose of the new medication. We do not make conversions such as “you were taking 14 mg, so start at 7.5 mg.” This is because, even within the GLP-1 class, your body’s adjustment does not carry over as is.
We do not use them together
Because both act on GLP-1 receptors, the risk of stronger side effects is higher than the chance of added benefit. Never obtain them through personal importation or other means and use them together on your own judgment.
What you should know while losing weight
Not losing muscle determines what happens after you stop
As you lose weight, you lose not only fat but also muscle. When muscle decreases, basal metabolism drops, and your body becomes more prone to gaining weight even with the same amount of food. Whether you are likely to regain weight after stopping the medication is largely determined by whether you protected your muscle while losing weight.
When your appetite is low, if you do nothing about it, your protein intake will fall along with your total intake. Instead of “not eating because I can’t eat,” switch to the idea of shifting the content of your smaller meals toward protein.
- 1Include protein at every meal (meat, fish, eggs, soy products, dairy products)
- 2Since you can eat less, eat protein before carbohydrates and fats
- 3Keep up light strength training or brisk walking, even just about twice a week
- 4Don’t add extreme carbohydrate restriction on top. When energy is insufficient, muscle is broken down first
If you only follow the number on the scale, you won’t notice a “failure that looks like success,” where only muscle has been lost. If possible, recording your waist circumference along with your weight lets you see what the change is made of.
Some people cannot use either medication
We cannot prescribe either medication to people who meet any of the following
- People who are pregnant or breastfeeding, or planning a pregnancy
- People with type 1 diabetes or diabetic ketoacidosis
- People with a history of pancreatitis
- People with a history of medullary thyroid cancer, or a family history of multiple endocrine neoplasia type 2
- People with a serious gastrointestinal disease that has reduced stomach motility
- People with a low BMI who do not medically need to lose weight
People using diabetes medications (SU drugs, insulin, etc.) are at risk of hypoglycemia. Please bring your medication record book to your consultation.
About self-pay treatment and off-label use
Using Rybelsus for medical weight loss (weight management) is “off-label use,” outside the scope of the indications approved in Japan. When considering it, please check the following points.
| Approval status in Japan | Rybelsus (semaglutide) tablets are a drug approved in Japan. However, the approved indication is “type 2 diabetes,” and use for weight management or dieting is outside the scope of approval (off-label use) and is self-pay treatment. |
|---|---|
| How we obtain it | The Rybelsus tablets prescribed at our clinic are drugs approved in Japan, obtained from a domestic pharmaceutical wholesaler (authorized distributor). Whether it can be prescribed and at what dose is decided by the doctor after a consultation. |
| Drugs with the same ingredient approved in Japan | As an injectable drug with the same active ingredient (semaglutide) as Rybelsus, “Wegovy Subcutaneous Injection” is approved in Japan for “obesity disease.” However, Wegovy has strict criteria for administration (such as BMI values and the presence of obesity-related health problems), and its prescription is limited to specific facilities. |
| Cost | Because it is off-label use, health insurance does not apply, and you pay the full cost (self-pay treatment). |
| Relief System for Adverse Drug Reactions (Japan) | This system provides relief for health damage that occurs when a drug is used properly in accordance with its approved indications, dosage and administration. If a serious side effect occurs with off-label use (such as for weight loss in self-pay treatment), it is not covered by this system (not eligible for benefits). |
| Main risks and side effects | Gastrointestinal symptoms such as nausea, diarrhea, constipation and stomach discomfort may appear early in treatment. Serious adverse reactions that may occur include acute pancreatitis, hypoglycemia, cholecystitis, cholangitis and cholestatic jaundice, bowel obstruction (ileus) and serious allergic reactions (anaphylaxis) (frequency unknown for all). |
Note that Mounjaro (tirzepatide) is also approved in Japan as a treatment for type 2 diabetes, and prescribing it for weight loss is likewise off-label use and self-pay treatment. For more about Mounjaro, see What is Mounjaro?
Approval status in other countries, safety and other information are summarized in What is Rybelsus? (about self-pay treatment and off-label use).
FAQ
QWhich one is more effective?
Because it acts on two receptors, Mounjaro may be expected to suppress appetite more strongly. However, side effects are also more likely, so “more effective” does not necessarily mean “right for you.” The decision also takes into account whether you can keep it up.
QIf Rybelsus doesn’t work for me, can I switch to Mounjaro?
Yes. However, if you have stayed on Rybelsus 3 mg, we will first consider increasing the dose to 7 mg. This is because in many cases people judge that it “doesn’t work” while still on the starting dose.
QDo the injections hurt?
The needle is thin and there is almost no pain. We explain how to inject and how to store the medication at your consultation, and you can also check our complete guide to injecting Mounjaro.
QWhat happens if I forget a Mounjaro injection?
If there are 72 hours (3 days) or more until your next scheduled dose, inject right away; if there are less than 3 days, skip that dose. Never inject two doses at once. For details, see If you forget a Mounjaro injection.
QWill the weight come back if I stop either one?
If you stop, the appetite that was being suppressed returns. How much weight comes back afterward depends on whether you got enough protein and maintained your muscle mass while using the medication.
QCan I use health insurance?
No. Both are approved as treatments for type 2 diabetes, and prescribing them for weight loss is off-label use and self-pay treatment.
QCan I get a prescription through online consultation?
Yes, we offer this. For details, see Online consultation for Mounjaro.
Not sure? Talk to us
Which medication suits you depends on your constitution, chronic conditions, current medications, lifestyle and goals. At our clinic, the consultation fee is free for both first visits and follow-up visits, and we also offer online consultation. If you have a chronic condition or take other medications, bringing your medication record book helps us decide more quickly.
For bookings and inquiries, please call our toll-free number 0120-241-929 (free call, 9:00–18:00) or contact us through our official LINE account. You can check prices in the price list.
*This article is intended to provide general information and does not indicate an individual diagnosis or treatment plan. Using Rybelsus, Mounjaro or metformin for weight loss is off-label use, and medical weight loss is self-pay treatment (you pay the full cost). Whether each person can use these medications and what dose is appropriate is decided by the doctor after a consultation and questionnaire. Please also see What is medical weight loss?
No consultation fee (first & follow-up visits)Online consultation available
Toll-free 0120-241-929 (toll-free in Japan, 9:00–18:00 JST, Japanese only)







